carbidopa

Generic: carbidopa

Labeler: novel laboratories, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name carbidopa
Generic Name carbidopa
Labeler novel laboratories, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carbidopa 25 mg/1

Manufacturer
Novel Laboratories, Inc.

Identifiers & Regulatory

Product NDC 40032-980
Product ID 40032-980_79b1eb69-36b1-41ca-8ecd-a90bcc361ac7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204763
Listing Expiration 2026-12-31
Marketing Start 2017-10-20

Pharmacologic Class

Established (EPC)
aromatic amino acid decarboxylation inhibitor [epc]
Mechanism of Action
dopa decarboxylase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 40032980
Hyphenated Format 40032-980

Supplemental Identifiers

RxCUI
260260
UPC
0340032980018 0340032980100
UNII
MNX7R8C5VO
NUI
N0000175754 N0000175755

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carbidopa (source: ndc)
Generic Name carbidopa (source: ndc)
Application Number ANDA204763 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (40032-980-01)
  • 30 TABLET in 1 BOTTLE (40032-980-03)
  • 1000 TABLET in 1 BOTTLE (40032-980-10)
source: ndc

Packages (3)

Ingredients (1)

carbidopa (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "79b1eb69-36b1-41ca-8ecd-a90bcc361ac7", "openfda": {"nui": ["N0000175754", "N0000175755"], "upc": ["0340032980018", "0340032980100"], "unii": ["MNX7R8C5VO"], "rxcui": ["260260"], "spl_set_id": ["7e5c9666-7a7c-4b64-87e4-7be6ae53603e"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "manufacturer_name": ["Novel Laboratories, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (40032-980-01)", "package_ndc": "40032-980-01", "marketing_start_date": "20171020"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (40032-980-03)", "package_ndc": "40032-980-03", "marketing_start_date": "20171020"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (40032-980-10)", "package_ndc": "40032-980-10", "marketing_start_date": "20171020"}], "brand_name": "Carbidopa", "product_id": "40032-980_79b1eb69-36b1-41ca-8ecd-a90bcc361ac7", "dosage_form": "TABLET", "product_ndc": "40032-980", "generic_name": "Carbidopa", "labeler_name": "Novel Laboratories, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbidopa", "active_ingredients": [{"name": "CARBIDOPA", "strength": "25 mg/1"}], "application_number": "ANDA204763", "marketing_category": "ANDA", "marketing_start_date": "20171020", "listing_expiration_date": "20261231"}